Objective: Fatty acids are important for biological function; however, in excess, they can cause metabolic dysregulation. Methods to image and detect fatty acids in real time are lacking. Therefore, the current study examined the dynamics of fatty acid trafficking and signaling utilizing novel fluorescent and luminescent approaches. Methods: We generated fluorescent and luminescent-based genetically-encoded sensors based upon the ligand-dependent interaction between PPARa and SRC-1 to image and detect cellular dynamics of fatty acid trafficking. Results: The use of a fluorescent sensor demonstrates that fatty acids traffic rapidly from lipid droplets to the nucleus. Both major lipases ATGL and HSL contribute to fatty acid signaling from lipid droplet to nucleus, however, their dynamics differ. Furthermore, direct activation of lipolysis, independent of receptor-mediated signaling is sufficient to promote lipid droplet to nuclear trafficking of fatty acids. A luminescent-based sensor that reports intracellular fatty acid levels is amenable to high-throughput analysis. Conclusions: Fatty acids traffic from lipid droplets to the nucleus within minutes of stimulated lipolysis. Genetically-encoded fluorescent and luminescent based sensors can be used to probe the dynamics of fatty acid trafficking and signaling.
INTRODUCTION
Fatty acids (FAs) are a significant energy source and substrates for membrane synthesis that are required for cellular growth and division. Importantly, recent work has identified a role for FAs as signaling molecules in regulating lipid homeostasis [1] . On the other hand, excessive levels of FAs can lead to a build up of toxic lipid metabolic intermediates in a process termed lipotoxicity [2] . This buildup of lipids can have negative effects that are causative in various metabolic disorders, such as diabetes [3] and cardiovascular disease [4] . However, our understanding of FA metabolism has been hampered by the lack of methods to detect their production in a temporal and spatial manner in live cells. FAs are stored safely in the form of triacylglycerol (TAG) within lipid droplet (LD) organelles [5] . During times of energy demand these stores are mobilized by lipases on the surface of LDs. In adipocytes, this process is mediated by the major lipases adipose triglyceride lipase (ATGL; also known as Patatin Like Phospholipase Domain Containing 2, PNPLA2), the rate limiting enzyme for TAG hydrolysis and hormone sensitive lipase (HSL), a major diacylglycerol (DAG) lipase [6] . In brown adipocytes (BAs), FAs are essential regulators of thermogenesis [7, 8] by supplying energy for mitochondrial electron transport and functioning as allosteric activators of uncoupling protein 1 (UCP1) [9] , the molecular mechanisms for brown adipose tissue non-shivering thermogenesis. Recent work has demonstrated that ATGL and HSL can regulate the transcription of various genes involved in FA metabolism and uncoupling such as peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1a), pyruvate dehydrogenase kinase 4 (PDK4), and UCP1, likely by providing ligands for nuclear transcription factors peroxisome proliferator-activated receptors (PPARs) [10e13]. However, the temporal and spatial regulation of how FAs might traffic to promote gene expression is not known. In addition, methods to detect real time mobilization of intracellular FAs are lacking. Here we describe the development of genetically-encoded sensors based upon the ligand-dependent interaction between PPARa and steroid receptor coactivator-1 (SRC-1) to image the production and trafficking of FAs by fluorescent and luminescent means.
METHODS AND EXPERIMENTAL PROCEDURES

cDNA cloning and generation of cell lines
Cloning for the PPARa ligand binding domain (LBD) and the SRC-1 fragment were previously described [10] . Briefly, the bipartite FA sensor was generated by first cloning the LXXLL domain of SRC-1 (amino acids, aa; 620e770) on the C-terminus of EYFP (Clontech). The LBD of human PPARa (aa 191e467) was cloned on the C-terminus of full-length Perilipin-1 (PLIN1). The PLIN1-PPARa LBD fusion was then sub-cloned on the C-terminus of EYFP-SRC1 separated by a P2A sequence. The cDNA for a monomeric luciferase FA sensor was commercially synthesized (Genewiz Inc.). Briefly, Gaussia luciferase (Gluc) was split into optimized N-terminal (aa 18e105; GlucN) and C-terminal fragments (aa 106e185; GlucC) as previous described [14] . The GlucN fragment was followed by the LBD of PPARa, the LXXLL motif of SRC-1 and finally the GlucC fragment. Each fragment was separated by flexible linkers 2X(Gly-Gly-Gly-Gly-Ser). The synthesized DNA fragment containing AgeI and XbaI sites was cloned into the same sites of ECFP-C1. The indicated constructs were cloned into the lentivirus vector (pIN-DUCER20) as previously described [15, 16] . For lentiviral packaging, pINDUCER20 target plasmid was co-transfected with pMD2.G and psPAX2 packaging vectors into HEK293T cells using lipofectamine LTX and plus reagent (Invitrogen). 48 h and 72 h post transfection, viruscontaining culture media was harvested and passed through 0.45 mM filters to remove debris. To collect the virus, the media was centrifuged at 48,000Â g for 2 h 4 C in a Beckman 25.50 fixed angle rotor, and the virus pellet was resuspended in OPTIMEM. Stable brown adipocyte (BA) cells line expressing sensors were generated by infecting with virus for 24 h followed by G418 selection (800 mg/ml) for one week.
Cell culture
HEK293T and COS-7 cells were purchased from ATCC. Mouse brown preadipocyte cells lines were generated in the labs of Dr. Bruce Spiegelman (Harvard University) or Dr. Gregory Steinberg (McMaster University) and were provided as gifts. All cells were maintained in DMEM High Glucose (Hyclone GE Lifesciences) with 10% FCS (Atlanta Biologicals) and Penicillin/Streptomycin (Hyclone, GE Lifesciences). Brown preadipocytes were differentiated by treating cells with induction medium (20 nM insulin, 1 nM T3, 0.5 mM isobutylmethylxanthine, 0.5 mM dexamethasone, and 0.125 mM indomethacin) for 48 h, followed by maintenance in differentiation media (20 nM insulin, 1 nM T3) until complete differentiation at 7 days. The expression of stably integrated sensors was induced by treating cells with 1 mg/ml doxycycline for 24e48 h.
Microscopy
Images were acquired using an Olympus IX-81 microscope equipped with a spinning-disc confocal unit. Microscope control and data acquisition were performed using CellSens Dimensions (Olympus) software. BAs grown and differentiated on 35 mm glass coverslips were imaged in HEPES-Krebs-Ringer buffer (Sigma) supplemented with 1% BSA (Alkali Scientific). EYFP fluorescent images were acquired using a 40 Â (0.9 NA) or 60 Â (1.2 NA) water immersion lens. EYFP reporter images were acquired every minute, with basal fluorescence recorded for the first 3e5 min, followed by stimulation of lipolysis (forskolin/IBMX, 2 mM and 200 mM; ABHD5 ligand; isoproterenol). The region of interest (ROI; lipid droplets, nucleus or cytoplasm) for each frame was quantified using ImageJ software (NIH) and the LD or nucleus ROI was normalized to cytoplasm to correct for any nonspecific changes in fluorescent intensity due to minor changes in excitation or focal plane. Data were then expressed as a fold of basal fluorescence.
Immunofluorescence
BAs grown on 35 mm glass coverslips were induced to express the fluorescent FA sensor for 48 h. Cells were treated with vehicle or Isoproterenol for 20 min as above for microscopy experiments. Fixed cells were permeabilized with phosphate-buffered saline containing 5% normal donkey serum and 0.01% saponin (Permeabilization buffer) for 15 min, then incubated for 50 min in Permeabilization buffer with primary antibody against PLIN1 (goat, 1:200, Everest Biotech, Cat# EB07728). The slides were washed four times, 5 min each, with phosphate-buffered saline, then incubated for 1 h with Alexa Fluor 555 conjugated donkey anti-goat (1:1000; Invitrogen) in Permeabilization buffer. The slides were washed again, then counterstained for nuclei (4 0 ,6-diamidino-2-phenylindole; 1:5000) in phosphate-buffered saline. Slides were finally washed with phosphate-buffered saline and imaged as above on an Olympus IX-81.
Gene expression analysis
RNA was isolated from BAs using a Nucleospin RNA II kit (Machery-Nagel) as indicated by the manufacturer. Total RNA was reverse transcribed using Superscript III (Invitrogen) with oligo(dT) primers (ThermoFisher). Fifty nanograms of cDNA was analyzed in a 20-ml quantitative PCR reaction (ABsolute Blue QPCR SYBR; Thermo-Scientific) with 80 nM of primers. Expression data were normalized to the housekeeping gene peptidylprolyl cisetrans isomerase A (PPIA) using the DDC T method (2 ÀDDCT ) [17] . cDNAs were amplified using primers as previously described [10] .
2.6. Luciferase assays Immediately following treatments, cells were washed once with PBS and luciferase assays were performed by lysing cells in Gluc assay 
Biochemical measurements
Fatty acids released in the media were determined using a WAKO NEFA HR kit (Wako Pure Chemicals Industries) adapted to fluorescence detection with Amplex Red (Cayman Chemical). Glycerol was quantified using the Free Glycerol (Sigma) reagent with colorimetric determination.
RESULTS
Fluorescent imaging reveals dynamic trafficking of fatty acids from lipid droplets to nucleus
We previously described a fluorescent method to monitor the production of PPARa and PPARd ligands on LDs [10] . This assay involves targeting the ligand binding domain (LBD) of PPARa to the LD surface by fusing it to Perilipin 1 (PLIN1) and tagging the LxxLL motif of SRC-1 with EYFP. The presence of a FA (i.e., PPAR ligand) promotes the ligand dependent interaction between PPARa and SRC-1, which can be monitored by the accumulation of fluorescence at the LD surface. In addition to monitoring ligand production to genetically-targeted PPARa LBD, translocation of tagged SRC1 to endogenous nuclear receptors could provide a means of monitoring FA-induced transactivation in real time. To improve on the original design [10] , we incorporated the targeted LBD and fluorescent co-activator reporter into a single transcript using the P2A peptide to control relative expression levels. Furthermore, we put the construct under the control of a doxycycline inducible promoter ( Figure 1A ) and created a stable BA cell line that allowed controlled expression to detect the ligand dependent interaction ( Figure 1B ). In BA cells treated with doxycycline, EYFP-SRC-1 fluorescence was localized throughout the cytosol with some nuclear localization. Upon activation of protein kinase A (PKA) with forskolin/ IBMX to stimulate lipolysis, fluorescent EYFP-SRC1 rapidly translocated to the LD surface (arrowheads; Figure 1C ,D, Supplementary Movie 1), indicating that PPARa ligands (i.e. fatty acids) are immediately produced from LDs upon stimulation of lipolysis. Quantification of regions of interest (ROI) demonstrated a robust increase in EYFP fluorescence on the LD that occurred within 1e3 min of stimulating lipolysis. This early burst in the accumulation of EYFP was followed by a steady continuous accumulation in signal ( Figure 1E ). Somewhat unexpectedly, we also observed accumulation of EYFP-SRC1 within the nucleus (black arrows). The accumulation of EYFP-SRC1 in the nucleus steadily increased over 15 min and lacked the rapid phase observed at the LD surface ( Figure 1F ). We confirmed using immunofluorescence that the PLIN1-PPARa fusion remains on LD during stimulation (Supplementary Figure 1) . Thus, the translocation of EYFP-SRC1 to the nucleus most likely represents the FA-dependent interaction of EYFP-SRC1 with endogenous nuclear receptors ( Supplementary Figure 1) . These data demonstrate the rapid mobilization of FAs on LDs and their detection in the nucleus. Supplementary video related to this article can be found at https://doi. org/10.1016/j.molmet.2019.08.012 ATGL and HSL are the major adipocyte lipases which differ in their targeted substrates and mode of activation [6, 19] . In the basal state ATGL has weak TAG lipase activity; however, PKA activation phosphorylates PLIN1 to release the co-activator alpha-beta hydrolase domain-containing 5 (ABHD5, also known as CGI-58) [20] , which then activates ATGL [19] . In contrast, HSL is directly phosphorylated by PKA, which targets the lipase to LD surfaces and increases its activity [21, 22] . Both ATGL and HSL contribute to adipocyte lipolysis, acting as selective TAG and DAG lipases, respectively, yet how these lipases contribute the temporal and spatial mobilization of FAs has not been investigated. As shown in Figure 2A , activation of b-adrenergic receptors with isoproterenol (Iso) triggered a burst of EYFP-SRC1 fluorescence on LD surfaces within 2 min of activation, followed by a steady increase over the next 15 min. Pharmacological inhibition of HSL with BAY 59e9435 (BAY) [23] eliminated the rapid rise in fluorescence associated with LDs, but left largely intact the slower rise observed in control cells. Conversely, the rapid phase of FA mobilization was intact in the presence of ATGL inhibition with Atglistatin (Ai) [24] , yet enduring mobilization of FAs was largely eliminated in the absence of ATGL activity (Figure 2A) . These observations indicate that HSL can mediate a very rapid mobilization of FAs, and that ATGL is critical for sustained mobilization. Furthermore, results indicate that both lipases function in concert to achieve a full lipolytic response, consistent with experiments that monitor extracellular accumulation of FAs ( Supplementary Figure 2) . Fluorescent-tagged SRC-1 accumulation in the nucleus showed somewhat different kinetics, with no detectible burst and a slow accumulation that was similarly sensitive to inhibition of ATGL or HSL ( Figure 2B ). Consistent with the notion that ATGL and HSL are the Original Article major adipocyte lipases, dual inhibition of ATGL and HSL completely blocked the accumulation of EYFP-SRC1 ( Figure 2C ) on LDs and reduced accumulation in the nucleus by greater than 80% ( Figure 2D ). These data demonstrate that FAs can traffic from the LD to the nucleus through the function of ATGL and HSL and that these enzymes differ in their kinetics of FA mobilization on LDs.
The results with lipase inhibition indicate that PKA-induced HSL activation mediates rapid FA mobilization, whereas the sustained phase of LD-mediated FA signaling requires ATGL that might be independent of transmembrane signaling. To address the role of PKA activation in the temporal control of lipolysis, we compared receptor mediatedactivation by Iso with that induced by ABHD5 ligands, which activate ATGL-dependent lipolysis directly [15, 25] . These ligands stimulate lipolysis by binding ABHD5, reducing its affinity for PLIN1, thereby stimulating ATGL-dependent lipolysis independently of PKA. As expected, Iso promoted the increase in EYFP-SRC1 with two distinct phases, while direct activation of ABHD5 with SR-3420 promoted the steady accumulation of EYFP-SRC1 on the LD surface that lacked the initial burst observed with receptor activation (Figure 2E ). Interestingly, the profile of EYFP-SRC1 accumulation on LDs triggered by SR-3420 mimicked that of receptor mediated lipolysis when it was driven exclusively by ATGL (Figure 2A , BAY/Iso). The accumulation of EYFP-SRC1 within the nucleus was similar whether lipolysis was induced via activation of b-adrenergic receptors with isoproterenol or triggered by activation of ABHD5 with SR-3420 ( Figure 2F ). Overall, these results demonstrate that direct activation of lipolysis is sufficient to promote FA trafficking from LDs to the nucleus. The accumulation of EYFP-SRC1 within the nucleus suggested that FAs might traffic to the nucleus to modulate gene transcription via endogenous nuclear receptors. Because the fragment of SRC-1 used as a reporter lacks the activation domain, we reasoned that binding of this reporter to endogenous transcription factors might function as a dominant-negative to suppress the transcription of genes responsive to FA production. As shown in Figure 3A , Iso increased the expression of known PPAR target genes that are involved in fatty acid oxidation (PGC1a, PPARa, PDK4) and UCP1. Furthermore, doxycycline-induced expression of EYFP-SRC1 (þDox) lowered the expression of these genes but not expression of NOR-1 [10] , a direct PKA target gene. ( Figure 3A) . Importantly, the expression of the SRC-1 fragment did not affect the release of FAs ( Supplementary  Figure 3 ). Overall, these results indicate a LD to nucleus pathway that communicates the metabolic status of the cell to rapidly regulate the expression of genes involved in fatty acid oxidation and uncoupling.
A high throughput luciferase-based sensor to detect intracellular fatty acids
The fluorescent reporter provides local information on FA signaling. We next sought to determine whether the sensor system described could be adapted for high-throughput screening (HTS). To do so, we engineered luciferase complementation based on optimized fragments for a split Gaussia luciferase (Gluc) [26] into a single genetically-encoded reporter ( Figure 4A ). In HEK 293T cells transiently transfected with the luciferase sensor, the addition of PPAR ligands resulted in an increase in luciferase signal in response to PPARa ligands Wy14-643 (Wy) and GW7647, but not PPARg ligand rosiglitazone ( Figure 4B) . A dose response for Wy resulted in a calculated EC 50 of 0.54 mM, similar to the reported EC 50 values for this ligand ( Figure 4C ) [27, 28] . Overall, these results demonstrate that the luminescent based sensor is selectively responsive to PPARa ligands. We speculated that the PPARa Gluc sensor would be responsive to exogenous and endogenous FAs, which might provide a useful means of detecting intracellular lipolysis. To test the utility of the sensor we generated a stable BA cell line where the expression of the Gluc FA sensor could be controlled in doxycycline inducible manner. We first examined whether the luciferase sensor could detect exogenous FAs. Addition of oleic acid to cells increased the luciferase signal in a doseresponsive manner ( Figure 5A ). We next examined whether the luciferase sensor could detect endogenous FAs. BA cells were grown and differentiated, and the expression of the sensor was induced with doxycycline treatment for 24e48 h. Stimulation of lipolysis with the selective b3-adrenoreceptor agonist CL 316,243 (CL) increased lipolysis over a range of doses as determined by the accumulation of extracellular FAs, with a EC 50 of 8.5 nM ( Figure 5B ), similar to that previously reported [29] . The luciferase sensor similarly increased reporter activity in a dose responsive manner with a calculated EC 50 of 3.9 nM, demonstrating the utility of the sensor to detect FAs over a range of lipolysis activation ( Figure 5C ). We then examined whether the sensor was sensitive to inhibition of lipolysis. Treatment of BA cells with an inhibitor of HSL (BAY), the rate limiting enzyme for the hydrolysis of DAG, resulted in a reduction in luciferase activity when lipolysis was stimulated, but not under basal conditions ( Figure 5D ). We reasoned that the luminescent sensor was reporting the level of intracellular FAs. To test this, we increased the concentration of intracellular FAs by systematically lowering extracellular bovine serum albumin (BSA), the functional acceptor for FA efflux [30] . As expected, stimulation of the b-adrenergic receptor with Iso increased luminescence in cells incubated with 1% BSA and this effect was increased when the concentration of BSA was lowered to 0.1% and no BSA (0% BSA) ( Figure 5E ). When lipolysis was directly stimulated with ABHD5 ligand (SR-3420), which by-passes PKA signaling and negative feedback regulation on adenylyl-cyclase [30] , the effect was lower compared to Iso in the presence of 1% BSA. However, when the concentration of BSA was lowered to 0.5%, 0.1% and no BSA, SR-3420 had a much greater increase in luciferase activity. Lowering the concentration of BSA in the medium did not affect luciferase activity under basal conditions ( Figure 5E ). Overall, these data indicate that the luciferase sensor detects production of intracellular FA levels. We also examined whether cells expressing the luciferase reporter were amenable to culture in multi-well format for more highthroughput analysis. Brown pre-adipocyte cells were cultured directly in 96-well clear-bottom white luminescent plates. We first tested the sensitivity of the luciferase sensor to detect FAs of different chain length and saturation. Luminescence increased progressively with greater FA chain length starting with octanoic acid (C8:0), with long chain unsaturated FAs (C18:3, C18:1 and C22:6) demonstrating the greatest increase in luminescence ( Figure 6A ). Finally, we examined the utility of the FA luminescent sensor to screen for activators and inhibitors of lipolysis in a 96-well plate. The general b-AR agonist isoproterenol and chemical ABHD5 ligands SR-4995, SR-4559, and SR-3420 increased luminescent reporter activity ( Figure 6B ). The calculated Z' score from this assay was 0.627, indicating that the assay is sufficiently reliable for HTS [31] . The effects of isoproterenol and ABHD5 ligands were partly reduced with HSL inhibition, whereas inhibition of ATGL suppressed reporter activity to a greater degree. The efflux of FAs into the extracellular media paralleled the activity of the luciferase reporter ( Figure 6C ). The relationship between RLUs and FA concentration in this assay showed a linear response with a coefficient of determination of 0.95 ( Figure 6D ). These data indicate that the luminescent reporter detects lipolysis induced by different modes of chemical activation (receptor or ABHD5) and is amenable to highthroughput analysis.
DISCUSSION
Our ability to understand the role of FAs in metabolic homeostasis has been hampered by limitations to image and detect their production in cells. To address this barrier, we have developed genetically-encoded sensors that detect FAs by fluorescent and luminescent means. Using a fluorescent approach, we are able to image the temporal and spatial dynamics of FA trafficking within cells. Furthermore, a luminescentbased monomeric sensor reports intracellular FA levels and is amenable to high-throughput analysis. Using these approaches, we have improved our understanding of how FAs traffic and function within a cell.
Our previous work and that of others suggested a role for lipolytic enzymes in providing signaling molecules to regulate gene transcription [10, 12, 13] ; however, the temporal and spatial dynamics for this regulation have not been addressed. Using a fluorescence imaging approach, we took advantage of the ligand-dependent interaction between PPARa and SRC-1 and demonstrate that FAs produced by LDs can traffic to the nucleus within minutes of stimulating lipolysis. The exact mechanism by which FAs traffic from the LDs to the nucleus is currently unknown but might involve lipid binding proteins, such as fatty acid binding protein (FABP) 1 and 4, that traffic the ligands [32, 33] . ATGL and HSL are the major lipases in adipocytes; HSL is activated by phosphorylation and translocation to LDs, whereas ATGL is indirectly activated by the release of its co-activator ABHD5 from the scaffold protein PLIN1. Indeed, we found that the kinetics of ATGL and HSL signaling on LDs differed, with HSL activation required for the initial burst of FA release, and ATGL showing a steady increase in FA production on LDs. In contrast, both enzymes had a similar effect on promoting signaling in the nucleus, consistent with both enzyme regulating gene expression [10, 12, 34] . We also examined the effects of direct ABHD5 activation, independent of PKA stimulation, on lipid signaling. Interestingly, the effect of direct activation of ABHD5 (SR-3420) on FA production on LDs ( Figure 2E ) was similar to that which was seen when lipolysis was driven only by ATGL (i.e. with HSL inhibition, Figure 2A ). However, direct stimulation of ABHD5 resulted in an increase of FAs signaling to the nucleus similar to that of receptor activation (Iso), suggesting that direct stimulation of lipolysis is sufficient to promote signaling to the nucleus. Studies are currently underway to determine the effects of direct stimulation of ABHD5 on gene transcription. The accumulation of EYFP-SRC1 in the nucleus was somewhat surprising since the exogenous PPARa ligand binding domain was targeted to the LDs, suggesting that SRC-1 was trafficking to the nucleus in a ligand-dependent manner to bind endogenous nuclear receptors. Indeed, the binding of the SRC-1 fragment, lacking an activation domain, suppressed lipolysis-induced transcription of known PPAR target genes. However, pharmacological inhibition of both ATGL and HSL did not completely block the accumulation of EYFP-SRC1 within the nucleus (approximately 80% inhibition), suggesting that PKA-dependent effects on nuclear import or FA trafficking might exist [35, 36] . Quantification of FAs typically involves biochemical assays that use colorimetric or fluorescence-based methods to detect extracellular levels.
In addition, classical assays for determining PPAR transcriptional activity require transcription/translation events that can take several hours [27] . We reasoned that we could further take advantage of the liganddependent interaction between PPARa and SRC-1 to develop a monomeric sensor based on split Gluc. This sensor is able to detect synthetic PPARa ligands and endogenous FAs. Screening of FAs of varying chain length and saturation demonstrates that long-chain unsaturated FAs are potent PPARa ligands [27] . In BAs, the sensor accurately reports known potencies of a b3-AR agonist to stimulate lipolysis and PPARa agonists to induce gene transcription. Culture of BAs stably expressing the sensor in white 96-well format to test activators and inhibitors of lipolysis demonstrates that the sensor is amenable to HTS. Targeting lipolysis is of therapeutic interest, [1, 15] and the sensor could be used to screen for novel pharmacological probes that regulate lipolysis and/or PPARa ligands. Finally, expression of the luciferase sensor in transgenic animals could be used as an in vivo probe to monitor dynamics of FA production, uptake, and clearance, thereby improving our understanding of FA metabolism and their potential lipotoxic effects.
CONCLUSIONS
In summary, we have developed genetically-encoded sensors to determine the temporal and spatial dynamics of FA production, that typically would not be possible using more conventional approaches. Given the increased interest in studying FA metabolism and everexpanding obesity epidemic confronting our society, the use of these sensors will further improve our understanding of FA trafficking and metabolism. 
AUTHOR
